Loading...

Praxis Precision Medicines, Inc.

PRAX•NASDAQ
Healthcare
Biotechnology
$344.82
$15.22(4.62%)
U.S. Market opens in 49h 13m

Praxis Precision Medicines, Inc. (PRAX) Stock Overview

Explore Praxis Precision Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.3B
P/E Ratio-25.17
EPS (TTM)$-13.48
ROE-0.59%
Fundamental Analysis

AI Price Forecasts

1 Month$321.85
3 Months$198.69
1 Year Target$57.50

PRAX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Praxis Precision Medicines, Inc. (PRAX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.47, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $57.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -25.17 and a market capitalization of 7.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.62%
5-Day Change
5.69%
1-Month Change
17.03%
3-Month Change
10.62%
6-Month Change
98.21%
Year-to-Date (YTD) Change
16.99%
1-Year Change
857.83%
3-Year Change
2068.68%
5-Year Change
-26.27%
All-Time (Max) Change
-17.31%

Contact Information

https://www.praxismedicines.com
617 300 8460
99 High Street, Boston, MA, 02110

Company Facts

116 Employees
IPO DateOct 16, 2020
CountryUS
Actively Trading

Frequently Asked Questions